Form 8-K CESCA THERAPEUTICS INC. For: Feb 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Cesca Therapeutics (KOOL) Tops Q2 EPS by 5c
February 16, 2016 4:39 PM ESTCesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $4.32 million.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
... More